SK pharmteco commits over $200 million to expand CDMO infrastructure, adding 100 jobs over five years

SK pharmteco announced a plan to invest at least $200 million in building out its development and manufacturing infrastructure over the next five years.

The funding is aimed at expanding the company's contract development and manufacturing organization (CDMO) capabilities to serve a broader client base.

The expansion is projected to create roughly 100 new jobs, underscoring growth in the pharmaceutical manufacturing sector.